| pubmed-article:8491812 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8491812 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8491812 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8491812 | lifeskim:mentions | umls-concept:C0042036 | lld:lifeskim |
| pubmed-article:8491812 | lifeskim:mentions | umls-concept:C0039674 | lld:lifeskim |
| pubmed-article:8491812 | lifeskim:mentions | umls-concept:C0680730 | lld:lifeskim |
| pubmed-article:8491812 | lifeskim:mentions | umls-concept:C1148554 | lld:lifeskim |
| pubmed-article:8491812 | lifeskim:mentions | umls-concept:C0008565 | lld:lifeskim |
| pubmed-article:8491812 | lifeskim:mentions | umls-concept:C0074559 | lld:lifeskim |
| pubmed-article:8491812 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8491812 | pubmed:dateCreated | 1993-6-16 | lld:pubmed |
| pubmed-article:8491812 | pubmed:abstractText | Tetrahydropapaveroline (THP) concentrations were measured in the urine of Parkinsonian patients receiving L-dopa-carbidopa (Sinemet) therapy, using a method that employs a separation scheme that selectively isolates THP from urine and utilizes the Pictet-Spengler condensation of THP with formaldehyde combined with high-performance liquid chromatography for identification and determination. The mean (+/- S.D.) recoveries of THP from normal urine with 0.2 pmol/ml added and from Parkinsonian patients' urines with 0.5 pmol/ml added were 48.6 +/- 5.7 and 44.6 +/- 3.1%, respectively. Three Parkinsonian patients who were receiving either 250, 750 or 1000 mg of L-dopa (as Sinemet) daily had 24-h urinary THP excretion levels of 989, 1017 and 1600 pmol, respectively. | lld:pubmed |
| pubmed-article:8491812 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8491812 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8491812 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8491812 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:8491812 | pubmed:issn | 0021-9673 | lld:pubmed |
| pubmed-article:8491812 | pubmed:author | pubmed-author:CashawJ LJL | lld:pubmed |
| pubmed-article:8491812 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8491812 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:8491812 | pubmed:volume | 613 | lld:pubmed |
| pubmed-article:8491812 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8491812 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8491812 | pubmed:pagination | 267-73 | lld:pubmed |
| pubmed-article:8491812 | pubmed:dateRevised | 2009-10-6 | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:meshHeading | pubmed-meshheading:8491812-... | lld:pubmed |
| pubmed-article:8491812 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8491812 | pubmed:articleTitle | Determination of tetrahydropapaveroline in the urine of parkinsonian patients receiving L-dopa-carbidopa (Sinemet) therapy by high-performance liquid chromatography. | lld:pubmed |
| pubmed-article:8491812 | pubmed:affiliation | Veterans Affairs Medical Center, Houston, TX 77030. | lld:pubmed |
| pubmed-article:8491812 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8491812 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
